Speech-Language Pathologists in Peoria, AZ Accepting Medicare

50 Speech-Language Pathologists found. Showing 41 - 50

Bradley D Rice Jr., M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22881 N 103rd Ln, Peoria, AZ 85383 Phone: 847-890-5703    Fax: 833-815-2428

Mrs. Eugenia Vasilakos Kellenberger, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22253 N 102nd Ln, Peoria, AZ 85383 Phone: 480-335-4261

Mrs. Julie Renee Rowe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6815 W Cactus Rd, Peoria, AZ 85381 Phone: 623-937-5090    Fax: 623-937-5349

Meredith Coleman, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9385 W Donald Dr, Peoria, AZ 85383 Phone: 623-547-6715

Julie Greseth Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7677 W Paradise Ln Apt 1146, Peoria, AZ 85382 Phone: 928-533-2275

Myra Susan Williams, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7231 W North Ln, Peoria, AZ 85345 Phone: 757-285-4377

Maggie Esbenshade Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8624 W Sweetwater Ave, Peoria, AZ 85381 Phone: 623-412-4850

Rise Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22881 N 103rd Ln, Peoria, AZ 85383 Phone: 847-890-5703    Fax: 833-815-2428

Jared Woodruff Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8633 W John Cabot Rd, Peoria, AZ 85382 Phone: 623-412-4875

Ms. Misty Ann Mason, PH.D Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 11806 N 87th Ave, Peoria, AZ 85345 Phone: 602-999-6358

News Archive

Cephalon announces receipt of a Paragraph IV Certification Notice Letter regarding ANDA

Cephalon, Inc. (Nasdaq: CEPH) today announced receipt of a Paragraph IV Certification Notice Letter on October 20, 2009 regarding an Abbreviated New Drug Application (ANDA) submitted to the U.S. Food and Drug Administration (FDA) by Teva Pharmaceuticals USA, Inc. requesting approval to market and sell a generic version of the 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths of NUVIGIL® (armodafinil) Tablets [C-IV].

Are women more likely to develop long COVID?

Researchers found different groups of symptoms persisting after coronavirus disease 2019 (COVID-19), with fatigue and higher IL-6 levels common in women. About 75% of the patients they treated were women, indicating a link between sex hormones and immune response.

Study calls for improved mental health support for people affected by terrorist attacks

A government scheme to support the mental health of people affected by terrorist attacks needs to provide a better system of immediate psychological help, according to research led by the Care Policy and Evaluation Centre at the London School of Economics and Political Science.

Mayo Clinic to receive Biomarkers of Gut Function grant

Mayo Clinic announced today that it will receive funding through the Biomarkers of Gut Function and Health program within the Grand Challenges in Global Health initiative. This initiative was launched by the Bill & Melinda Gates Foundation to overcome persistent bottlenecks preventing the creation of new and better health solutions for the developing world. William Faubion, M.D., a Mayo Clinic gastroenterologist, will continue to pursue a research project titled "Gut Permeability in Environmental Enteropathy."

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3(current)